eldepryl 5 mg tablets
orion corporation - selegiline hydrochloride - tablet - 5 milligram(s) - monoamine oxidase b inhibitors; selegiline
rasagiline rowex 1 mg tablets
rowex ltd - rasagiline - tablet - 1 milligram(s) - monoamine oxidase b inhibitors; rasagiline - anti-parkinson drugs, monoamine oxidase b inhibitors - rasagiline rowex is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations
rasagiline teva 1 mg tablets
teva b.v. - rasagiline - tablet - 1 milligram(s) - monoamine oxidase b inhibitors; rasagiline - anti-parkinson-drugs, monoamine oxidase -b inhibitors - rasagiline teva is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
rasagiline actavis 1mg tablets
actavis group ptc ehf - rasagiline tartrate - tablet - 1 milligram(s) - monoamine oxidase b inhibitors; rasagiline
rasagiline clonmel 1 mg tablets
clonmel healthcare ltd - rasagiline - tablet - 1 milligram(s) - monoamine oxidase b inhibitors; rasagiline
rasagiline krka 1 mg tablets
krka, d.d., novo mesto - rasagiline - tablet - 1 milligram(s) - monoamine oxidase b inhibitors; rasagiline
apovomin 3 mg/ml solution for injection for dogs
dechra regulatory b.v. - apomorphine hydrochloride hemihydrate - solution for injection - 3 milligram(s)/millilitre - apomorphine
rasagiline accord 1 mg tablets
accord healthcare ireland ltd. - rasagiline - tablet - 1 milligram(s) - monoamine oxidase b inhibitors; rasagiline
rasagiline actavis 1mg tablets
accord healthcare ireland ltd. - rasagiline tartrate - tablet - 1 milligram(s) - monoamine oxidase b inhibitors; rasagiline
rasagiline mylan
mylan s.a.s. - rasagiline tartrate - parkinson disease - anti-parkinson drugs - rasagiline mylan is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.